Abstract Submission

More Information

Details

Starts
04/17/2020 9:00am
Ends
04/19/2020 2:00pm
Location
Marina Prk Hotel, Kish IsIand, Iran
Capacity
492

Registration Details

Status
Open
Begins
08/10/2019 12:00am
Ends
01/31/2020 12:00am

"The 10th General Assembly and Scientific Conference of APOCP, 17-19 April, 2020, Kish Island, Iran"

Greeting

It is our pleasure to inform you that The 10th General Assembly and International Conference of Asian Pacific Organization for Cancer Prevention (APOCP-10) will be held in Kish Island, Iran from April 17th to 19th, 2020. Since the foundation of APOCP in 2000, we have brought people together to promote cancer prevention and collaborative studies in the Asian Pacific regions.

We believe the APOCP-10 will provide significant opportunities to exchange mutual information, ideas and achievements, and to facilitate continuous growth of APOCP activities on cancer prevention and control in this region. On behalf of the organizing committee, we are honored to invite you to the APOCP-10.

We are sure that your participation will ensure an invaluable learning ground and will help us make a bigger step forward in reaching a milestone. The 10th APOCP general assembly will celebrate an important milestone for APOCP. The milestone that moves APOCP from a scientific association to an officially international cancer science organization.

Kish Island, or the marble of Persian Gulf, is a beautiful natural scenery with many historic landmarks. Please come to visit Kish Island to take a relaxed and enjoyable time.

Esmaeil Akbari, MD

Dr. Alireza Mosavi jarrahi, MSPH, Ph.D.

Prof. YouLin Quai, MD, Ph.D.

President, APOCP 10th Scientific Conference

 

President, Asian Pacific Organization for Cancer Prevention

General Secretary, Asian Pacific Organization for Cancer Prevention

Scientific Theme

The scientific theme of the meeting covers all aspect of cancer control and prevention. There will be many sessions and halls. Specifically, the meeting has highlighted the following topics:

Cancer Epidemiology and Prevention

  • *      Cancer registry
  • *      Screening and early diagnosis
  • *      Life style and cancer
  • *      Cancer statistic and statistical modeling of cancer data
  • *      Cancer Biology in the context of cancer control

 

Cancer genetics and Molecullar aspect of cancer

  • *      Cancer vaccines 
  • *      Chimo-prevntion
  • *      Cancer and Environment

 

Cancer and Environment 

  • *      Carcinogenicity mechanism
  • *      CAREX and risk estimation
  • *      Carcinogens in occupational  setting
  • *      Climae change and cancer burden

 

Cancer Treatment and Management

  • *      Cancer cost and social aspect of cancer
  • *      Clinical trial and Advances in treatment
  • *      Cancer nursing, quality of life,
  • *      Cancer cost and economic burden
  • *      Social aspect of cancer

ORGANIZING COMMITTEE   

ORGANIZING COMMITTEE
LOCAL SCIENTIFIC COMMITTEE
REGIONAL SCIENTIFIC COMMITTEE
INTERNATIONAL ADVISORY COMMITTEE

Position

Name

Affiliation

President

Prof. MS Akbari

Special Advisor to Minister of Health, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran Iran

Chairman

Dr. Alireza Mosavi Jarrahi

General Secretary, West Asia Organization for Cancer Prevention, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran Iran

Administrative Secretary

Dr. Aliasghar Keramatinia

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran Iran

Public Relations Committee Chair

Rahil Jarrahi

West Asia Organization for Cancer Prevention, Tehran, Iran

Liaison & Arrangement Committee Chair

F. Karami

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran Iran

 

Local Scientific Committee

ORGANIZING COMMITTEE

LOCAL SCIENTIFIC COMMITTEE
REGIONAL SCIENTIFIC COMMITTEE
INTERNATIONAL ADVISORY COMMITTEE

Position

Name

Affiliation

Chair

Dr. Alireza Mosavi jarrahi

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran Iran

Members

Prof. Abas Ghaderi,

Shiraz Institute for Cancer Research (A.G.), Medical School, Shiraz University of Medical Sciences, Shiraz, Iran

Prof. Akram Pourshams

Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran

Prof. Abolfazl Movafagh

Department of Medical Genetics, Shahid Beheshti University of Medical sciences, Tehran, Iran

Prof. Mehrnoosh Doroudchi

Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz-Iran

Prof. Reza Shirkohi

Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran,

Prof. Mehdi Nematbakhsh

Professor, Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Prof. Manoochehr Makvandi

Virology Dept. Ahwaz University of Medical Sciences, Ahwaz, Iran

DR. Shapar Haghighat

Breast Research Center, Jahad Daneshgahi Organization, Tehran Iran

Dr. A. Motlagh

Cancer Office, Ministry of Health

Dr. Parasto Hajian

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran Iran

Dr. Saeid Doaei

School of Public Health, Gilan University of Medical Sciences, Rasht Iran

Dr. R. Moradzadeh

 

Department of Epidemiology, School of Public Health, Arak University of Medical Sciences, Arak. Iran

Dr. H. Salimzadeh,

Digestive Diseases Research Institute,  Tehran University of Medical Sciences, Tehran, Iran.

Dr. Afshin Moradi

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran Iran


Regional Scientific Committee

Name

Affiliation

Dr. Shahab Uddin

Hamad Medical Corporation, Academic Health System

Doha, Qatar

Dr. KHUSEYNOV AFARDZHON

Director of the Republic Oncological Scientific Center, Ministry of public health, Republic of Tajikistan

Dr. Abhishek Shankar

Department of Preventive Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital

All India Institute of Medical Sciences, Delhi, India

Dr. Niveen Abu-Rmeileh

 

Associate prof. of Community Medicine, Institute of Community and Public Health,

Birzeit University, Birzeit, Palestine

Dr. Rema Gvamichava

A. Gvamichava National Cancer Center,  Tbilisi State Medical University

Tbilisi, Georgia

Dr. Farhana Badar

 

Sr. Biostatistician & Cancer Epidemiologist, Cancer Registry & Clinical Data Management

Shaukat Khanum Memorial Cancer Hospital & Research Center, Lahore, Pakistan

Prof. Salim M. Adib

Professor of Public Health, American University of Beirut , Beirut, Lebanon

Prof. Ravi Mehrotra

 

National Institute of Cancer Prevention and Research, WHO-FCTC Global Hub for information on smokeless tobacco products, (Institute of Cytology and Preventive Oncology-ICMR), Department of Health Research, Noida, India

Prof. Abdulbari Bener

Dept. of Biostatistics & Medical Informatics, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul, TURKEY,

Dr. Munir Abu-Helalah

 

Regional Director Middle East, North Africa and Central Asia Global Academy for Health Sciences

Adjunct Associate Professor of Epidemiology and Preventive Medicine, AlFaisal University, Kingdome of Saudi Arabia

Prof. Omran S. Habib

Department of Community Medicine, College of Medicine, University of Basrah, Basrah, Iraq

Dr. Ahmad Farooqi

Senior Scientist | Institute of Biomedical and Genetic Engineering (IBGE), Islamabad, Pakistan

 

Dr. Gholamreza Roshandel

Director of the Iranian National Population-based Cancer Registry, Ministry of Health Medical Education, Tehran, Iran

Dr. Pratheeshkumar Poyil

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

 

International Advisory Committee

Name

Affiliation

Kazuo Tajima

Misugi Clinic, Japan /
Aichi Cancer Center Research Institute, Japan

Malcolm Moore

APJCP Editorial Office, U.K.

Cheng-Ha Yip

University of Malaya, Malaysia

Chien-Jen Chen

Academia Sinica, Taiwan

Jeff Dunn

University of Southern Queensland, Australia

You-Lin Qiao

National Cancer Center Cancer Hospital, China

Alireza Mosavi-Jarrahi

Shahid Beheshti University of Medical Sciences, Iran

Jin-Soo Lee

National Cancer Center, Korea

Yoon-Ok Ahn

Seoul National University, Korea

Young Joon Surh

Seoul National University, Korea

Nobuyuki Hamajima

Nagoya University, Japan

Murat Gultekin

Hacettepe University, Turkey

Barchuk Anton

Petrov National Oncology Center, Russia

Christopher Wild

International Agency for Research on Cancer, France

David Roder

University of South Australia, Australia

Hung Yi Chiou

Taipei Medical University, Taiwan

GRANTS:

TRAVEL GRANTS

YOUNG INVESTIGATOR AWARDS


YOUNG INVESTIGATOR AWARDS

Purpose of Awards

To support expenses for Young Investigators who have had an abstract accepted for presentation at the APOCP-9. The grant will be $500, and may vary depending on the number of applicants.

Terms

Applicants should be in a training position, i.e. students or postdoctor. Applicants should be the first author of the paper and the person presenting the original work.

Presentation

Applicants who have had an abstract accepted should present at the ‘Young Investigator Awardee Session’ on April 20 (Fri), 2018.

This session offer a unique opportunity for young investigators to expose their most innovative and novel research to renowned experts in the specific fields.

Awards Ceremony

The winners will be announced during the Awards Ceremony to be held on April 19, 2020.

Key Dates

Online Submission opens

01, October 2019

Deadline for applying for grants

Jan. 15, 2020

Notification on Acceptance

Jan 20, 2018

Travel and Accommodation Grants

Purpose of Grants

To support expenses for Young Investigators who have had an abstract accepted for oral presentation at the APOCP-10. There are 15 travel and 25 accommodation grants available to young scientists from the region who have submitted abstract and their abstract has been accepted as oral presentation.

Terms

Applicants should be at their early stage of their carrier development, i.e. students or postdoctor, assistant professor.  Applicants should be the presenting author of the submitted abstract and must attend in the meeting. The work must be an original work with a high degree of novelty (the APOCP-10’s scientific Committee evaluate orinigality and novelty). Applicant who would like to use these grant, must apply when they submit their abstract.

 

Key Dates

Online Submission opens

01, October 2019

Deadline for applying for grants

Jan. 15, 2020

Notification on Acceptance

Jan 20, 2018

Invited Speaker and keynote speakers

 

DR ELISABETE WEIDERPASS,

IARC DIRECTOR

Dr Elisabete Weiderpass, MD, MSc, PhD, is a Brazilian cancer researcher who is a naturalized Swedish and Finnish citizen. She is an expert in cancer epidemiology and cancer prevention. She took office as IARC Director on 1 January 2019.

 

DR DVID RODER,

University South Australia

Since 2011 David Roder has been Cancer Council SA’s Beat Cancer Project Research Chair of Cancer Epidemiology and Population Health at the University South Australia. He also works under contract with Cancer Australia, Cancer Institute NSW, and CanTeen. He presently chairs AIHW’s Cancer Monitoring Advisory Committee, the NSW Population & Health Services Research Ethics Committee, and the CanTeen Youth Cancer Service Data Advisory Panel.

 

PROF. REZA MALEKZADEH

Tehran University of Medical Sciences, Iran

Besides being a renowned gastroenterologist, Professor Malekzadeh has been instrumental in designing and executing an efficient and practical way of diagnosing cancerous and benign esophegal lesions in Iran, applicable to urban and rural areas.

Prof. Reza Malekzadeh received the "Permanent Personages Award" in the Third Permanent Personages session held on October 22, 2003. This national award is given to the most outstanding and memorable citizens of Iran.

 

Prof. Harri Vainio

Faculty of Public Health, Kuwait University, Kuwait

Professor Harri Vainio, M.D., Ph.D., is a researcher in preventive medicine and in occupational health and safety, specializing in risk assessment and management. Since October 2015, he serves as a Professor in Environmental and Occupational Health, Faculty of Public Health, Kuwait University. Prior to joining Kuwait University, Dr. Vainio was the Director General of the Finnish Institute of Occupational Health (FIOH), Helsinki, Finland for the years 2003-2015. 

 

Aleksey Belyaev ,

FSBI «N.N. Petrov NMRC of oncology» of the Ministry of

Healthcare of the Russian Federation,

 
 

Dr. Isabelle Heard

International Agency Research on Cancer, Lyon, France

Professor Isabelle Heard, MD, PhD, is a French Obstetrician and Gynecologist. Her clinical activity has been on HPV-infection and related disease in immunocompromised patients. She served as Director of the French National HPV Reference Centre at the Pasteur Institute for the last ten years. She is now Senior Visiting Scientist in the Prevention and Implementation Group at the International Agency for Research on Cancer (IARC), Lyon, France. 

 

Prof. Shahab Uddin

Hamad Medical Corporation, Academic Health System, Doha, Qatar

Dr. Shahab Uddin is a Senior Scientist and Head of Molecular Pathophysiology, at Transnational Research Institute, Hamad Medical Corporation, Doha, Qatar.  In 2003, he joined King Faisal Specialist Hospital & Research Centre, Riyadh, KSA, as a Scientist initially (2003-2005) and subsequently promoted to Senior Scientist (2005) and deputy director of Human Cancer Genomic Program. Dr. Shahab contributed to the establishment of Human Cancer Genomic Program at King Faisal Specialist Hospital & Research Centre for translational research.   Currently, he is working as Senior Scientist and Head of Molecular Pathophysiology section in interim Translational Research Institute at Hamad Medical Corporation, Doha, Qatar.

 

DR KEUN-YOUNG YOO,

Seoul National University College of Medicine
Seoul | South Korea

Dr. Keun-Young Yoo has received medical degree from Seoul National University College of Medicine in 1978, MPH at SNU School of Public Health in 1981, and was awarded a PhD at SNU in 1985.  His major interest is in female cancer epidemiology, risk factor analysis, genetic susceptibility and prevention of cancer, and global health. He has published 304 articles, and has edited 32 books on cancer epidemiology and control, biostatistics, and cancer awareness for the public.

 

DR MALCOLM ANTONY MORE,

APOCP FOUNDER.

 

DR KAZUO TAJIMA,

Misugi Clinic, Japan

 

DR JEFF DUNN,

University of Southern Queensland, Australia.

 

DR YOULIN QIAO,

Chinese Academy of Medical Sciences, China

 

DR LE TRAN NGOAN,

Hanoi Medical University, Vietnam.

 

DR NOBUYUKI HAMAJIMA,

Nagoya University, Japan.

 

PROF. SHAHID PERVEZ,

Faculty of Health Sciences, Medical College, The Aga Khan University, Karachi, Pakistan.ARC DIRECTOR.

 

DR CHENG-HAR VIP,

Ramsay Sime Darby Health Care, Malaysia.

 

DR ANTON BARCHUK,

Petrov National Research Center of Oncology, Russia.

 

Sponsors and collaborators:

Asian Pacific Organization for Cancer Prevention (APOCP)  
   
Cancer Research Center, Shahid Beheshti University of Medical Sciences  
   
Cancer Research center, Tehran University of Medical Sciences  
   
West Asia Organization for Cancer Prevention  
   
Iranian Cancer Association